Skip to content

Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)

Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02975050
Acronym
ViVUS
Enrollment
30
Registered
2016-11-29
Start date
2016-11-28
Completion date
2017-01-19
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Volunteer Validation Study

Brief summary

This study has the following objective: • To validate the capability of the μ-Cor System to monitor ECG, Heart Rate (HR), Respiration Rate (RR), Posture and Activity in healthy human subjects. The μ-Cor validation will be demonstrated at two body locations: 1. Side location (below left armpit) for study arm 1, and 2. Front location (upper left chest) for study arm 2 An FDA-cleared comparator device will be used to support the validation of the study device.

Detailed description

This study has the following objective: • To validate the capability of the μ-Cor System to monitor ECG, Heart Rate (HR), Respiration Rate (RR), Posture and Activity in healthy human subjects. The μ-Cor validation will be demonstrated at two body locations: 1. Side location (below left armpit) for study arm 1, and 2. Front location (upper left chest) for study arm 2 An FDA-cleared comparator device will be used to support the validation of the study device.

Interventions

OTHERLocation

Sponsors

Zoll Medical Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject is at least 21 years of age or older. * Subject is willing and able to sign the Informed Consent Form. * Subject is healthy, able and willing to complete all the preparation steps and study procedures.

Exclusion criteria

* Female subject with a known pregnancy or unsure about pregnancy status. * Subjects with allergies and/or skin sensitivities to electrode hydrogel and/or acrylic based adhesive. * Subjects with skin breakdown in areas where device placement is required. * Subjects with chronic lung disease or asthma. * Subjects with a history of cardiovascular diseases. * Subjects who are diabetic. * Subjects living with kidney failure or dialysis. * Subjects with a history of liver failure. * Subjects with any known malignancy (i.e. cancer patients). * Subjects with implanted devices in the thoracic region

Design outcomes

Primary

MeasureTime frameDescription
Respiratory rateImmediatelyThe difference between the μCor RR and the comparator RR will be lower than 2.8bpm (STD).
PostureImmediately90% agreement between the positions (supine / reclined / upright) derived from μCor reporting and the known position
ActivityImmediatelyμCor output is provided as active and not active. 90% correct classification of activity will be required of recordings.
Heart RateImmediately
ECGImmediately

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026